Prospective Clinical Study to Evaluate the Safety and Efficacy of Versius in Robot-Assisted Total Hysterectomy
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The objective of this clinical trial is to expand the clinical evaluation of the safety and efficacy of Versius in gynaecology procedures of total robotic assisted hysterectomy and/or salpingo-oophorectomy
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 22
Healthy Volunteers: f
View:
• Female, aged 22 years or above, who provided written informed consent to participate in the study.
• Patient deemed suitable for minimally invasive total hysterectomy and/or Salpingo-Oophorectomy, for benign condition.
• Patient with BMI ≤40.
Locations
Other Locations
Poland
Uniwersyteckie Centrum Kliniczne im. prof. K. Gibińskego Śląskiego Uniwersytetu Medycznego w Katowicach
RECRUITING
Katowice
Contact Information
Primary
Mark Slack, MD
mark.slack@cmrsurgical.com
+44 7766 024389
Backup
Chad Schaber, PhD
chad.schaber@cmrsurgical.com
Time Frame
Start Date: 2025-07-25
Estimated Completion Date: 2026-01
Participants
Target number of participants: 45
Treatments
Experimental: Surgery with Versius
Related Therapeutic Areas
Sponsors
Collaborators: Uniwersyteckie Centrum Kliniczne im. prof. K. Gibińskego Śląskiego Uniwersytetu Medycznego w Katowicach
Leads: CMR Surgical Ltd